Rheumatoid Arthritis Real-world Cohort Study in China (ReALSA) - Trial NCT06233929
Access comprehensive clinical trial information for NCT06233929 through Pure Global AI's free database. This phase not specified trial is sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University and is currently Not yet recruiting. The study focuses on Rheumatoid Arthritis. Target enrollment is 2000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Timeline & Enrollment
N/A
Mar 01, 2024
Mar 01, 2033
Primary Outcome
Myopenia,CVDs
Summary
An ongoing long-term cohort study is conducted in the Sun Yat-sen Memorial Hospital of Sun
 Yat-sen University, that is dedicated to recruiting RA patients, to identify the development
 of clinical, neuroimaging, and biochemical biomarkers for the diagnosis and prognosis of RA,
 especially for those with sarcopenia/myopenia
 
 To improve the prognosis of RA, this study includes the following objectives:
 
 1. Construct a useful database to explore the secular dynamic progress of RA, especially
 the difference between early and lately RA, as well as to improve our understanding of
 the life-course factors affecting the process that will facilitate future research
 activities.
 
 2. Identify the potential markers (clinical, biomedical and imaging) affecting/predicting
 the development process of sarcopenia/myopenia or other prognosis in RA patients.
 
 3. Develop the related multi-modal prediction models with clinical, biomedical and imaging
 variables to improve the diagnosis and prognosis of RA.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06233929
Non-Device Trial